Academic Director

Prof. Dr. Monika Schäfer-Korting

Prof. Dr. Monika Schäfer-Korting

Prof. Monika Schäfer-Korting is the Academic Director of the master’s degree course in Drug Research and Management in the Department of Health Care at DUW. She is Professor of Pharmacology and Toxicology at Freie Universität Berlin. Areas of emphasis in her research include the integrative development of innovative drugs and delivery systems; nanodimensioned drug delivery systems for the treatment of inflammatory skin diseases and skin tumors (two patents); improving the benefit-to-risk ratio of drugs; alternatives to animal testing of chemicals and drugs.

 

E-Mail: DRM@duw-berlin.de

Curriculum vitae

Prof. Monika Schäfer-Korting studied pharmacology and received her doctorate in 1977, and her habilitation in 1989, at the University of Frankfurt am Main. From 1978 to 1979 she was a postdoctoral researcher at Technische Universität, Munich.

From 1992 to 1994 she was interim professor at Freie Universität Berlin. In 1994 she became the first holder of a new chair in Pharmacology and Toxicology in the Institute for Pharmacology at Freie Universität Berlin. From 1997 to 1999 she served as Vice-President for Natural Sciences and Research at Freie Universität Berlin. From 2003 to 2006 Prof. Schäfer-Korting coordinated the research alliance on measuring skin resorption with bioengineered human skin, funded by the Federal Ministry of Education and Research. Since 2003 she has been the spokeswoman of DFG Research Group 463, “Innovative Drugs and Delivery Systems.”

Since 2004 Prof. Schäfer-Korting has been a member of the Veterinary Ethics Committee of the University of Vienna. Since 2005 she has been a member, and Chair of the Scientific Advisory Board, of the Federal Institute for Risk Assessment, Berlin. She has been Vice-President of Freie Universität Berlin since 2007. At DUW, Prof. Schäfer-Korting is Academic Director of the master’s degree programme in Drug Research and Management.

Drug Research and Management

Dr. rer.nat. Annette Schappach

Dr. rer.nat. Annette Schappach

Dr. Annette Schappach is Course Director of the master’s degree course in Drug Research and Management in the Department of Health Care at DUW. After graduating in Pharmacology at Freie Universität Berlin, Dr. Schappach passed her board examination as a pharmacist in 1992, and earned her doctorate in 2000 under Prof. H.-D. Höltje.

 

E-Mail: DRM@duw-berlin.de

Curriculum vitae

Since April 1, 2010, Course Director of the new continuing education master’s degree course in Drug Research and Management in the Department of Health Care at DUW.

Degree in pharmacology, Freie Universität Berlin Berlin. 1992, pharmacy board examination. Four years’ experience as a pharmacist in Berlin. 1996–1999, research assistant, Department of Pharmaceutical Chemistry, University of Düsseldorf, with duties including teaching and supervising internships in the university’s course in pharmacy. January, 2000, doctorate under Prof. H.-D. Höltje.

2000–March, 2010, Research Associate and Advisor, Department of Clinical Research, Medical Science and Drug Safety; from 2006 on also Deputy Qualified Person for Pharmacovigilance (QPPV); from 2008 on also Deputy Safety Officer for Medical Products, Bausch&Lomb/Dr. Mann Pharma, Berlin.

Instructors

  • Dr. Tobias Boeckh, Hertin law firm, Berlin
  • Dr. René Brecht, ProBioGen AG, Berlin
  • Dr. Jörg Brüggmann, Unfallkrankenhaus Berlin
  • Dr. Gudrun Busch, Lohmann Animal Health GmbH & Co. KG, Cuxhaven
  • Dr. Eva Cendon, Deutsche Universität für Weiterbildung (DUW), Berlin
  • Dr. Caroline Cornelius, Psychologist, Caro Line Coaching/Moderation/Training, Konstanz
  • Katharina Cortolezis-Schlager, team consult, Vienna
  • Dr. Andreas Emmendörffer, Agenolab GmbH & Co. KG, Stuttgart
  • Susanne Hastrup, CSL Behring AG, Bern, Switzerland
  • Prof. Hans-Dieter Höltje, University of Düsseldorf
  • Dr. Brigitte Holzhauer, Holzhauerei Market and Social Research, Mannheim
  • Prof. Stefan Kammhuber, Fachhochschule Koblenz
  • Prof. Ekkehard Kappler, University of Innsbruck
  • Dr. Friedhelm Kirmeier, Sanofi-Aventis Deutschland GmbH, Berlin
  • Michael Klein, LL.M., University of Minnesota, Pfizer Deutschland GmbH, Berlin
  • Prof. Burkhard Kleuser, Freie Universität Berlin
  • Prof. Jochen Koch, European University Viadrina, Frankfurt (Oder)
  • Prof. Hans Christian Korting, University Hospital, Munich
  • Jan Kresken, LL. M., Norwich Law School, University of East Anglia
  • Friedhelm Leverkus, Pfizer Deutschland GmbH, Berlin
  • Dr. Andreas Luch, Federal Institute for Risk Assessment, Berlin
  • Prof. Jörg Luy, Freie Universität Berlin
  • Prof. Matthias F. Melzig, Freie Universität Berlin
  • Anita Mörth, Deutsche Universität für Weiterbildung (DUW), Berlin
  • Dr. Karl-Heinz Nietsch, Sanofi-Aventis Deutschland GmbH, Berlin
  • Dr. Karlheinz Nocker, Reiskirchen
  • Prof. Ada Pellert, Deutsche Universität für Weiterbildung (DUW), Berlin
  • Prof. Angelika Richter, Freie Universität Berlin
  • Prof. Ivar Roots, Charité University Hospital, Humboldt-Universität, Berlin
  • Dr. Katrin Roscher, Sanofi-Aventis Deutschland GmbH, Berlin
  • Prof. Uwe Rösler, Freie Universität Berlin
  • Prof. Monika Schäfer-Korting, Freie Universität Berlin
  • Katharina Schiederig, Freie Universität Berlin
  • Michael Schipperges, M. A. I. A., Sociodimensions Institute for Socio-Cultural Research, Heidelberg
  • Prof. Horst Spielmann, Federal Institute for Risk Assessment, Berlin; Freie Universität Berlin
  • Dr. Berta C. Schreckeneder, Viewconsult, Munich
  • Prof. Johannes Peter Surmann, Freie Universität Berlin
  • Dr. Thomas Trilling, Basilea Pharmaceutica Deutschland GmbH, Munich
  • Gerhard Tschentscher, Pfizer Deutschland GmbH, Berlin
  • Gerhard Tschentscher, PFIZER Deutschland GmbH, Berlin
  • Prof. Dagmar Vinz, Freie Universität Berlin
  • Dr. Ralf Zuhse, Chiracon GmbH, Luckenwalde
 

Request for Information

Order now